DePuy Orthopaedics and parent company Johnson & Johnson are facing a growing multidistrict litigation (MDL), consisting of claims alleging adverse DePuy hip replacement symptoms.

One of the most recent claims comes from a Minnesota resident alleging serious DePuy hip replacement symptoms, which forced them to contend with contiguous medical treatment.

Plaintiff Lyle B. reportedly developed DePuy hip replacement symptoms not long after the metal on metal hip replacement system was implanted, side effects that were allegedly not mentioned on the product’s warning label. According to the DePuy metal hip lawsuit, Lyle opted for the DePuy ASR hip implant for typical treatment purposes and relied on the marketing statements made by the company.

With the assigned physician also looking over the advertisements, Lyle claims he had no reason to believe there was a risk of adverse DePuy hip replacement symptoms. According to the DePuy metal hip lawsuit, Lyle had the DePuy ASR hip implant implemented on the left hip on Nov. 14, 2008.

However not long after the device was implanted, Lyle reportedly began experiencing painful DePuy hip replacement symptoms that impacted the patient’s quality of life. These adverse DePuy hip replacement symptoms allegedly caused Lyle to suffer a number of painful side effects including pain, stiffness, discomfort, locking, and weakness.

These complications eventually forced Lyle to undergo revision surgery to remove the DePuy ASR hip replacement system, according to the complaint. Lyle says he will need long-term medical monitoring for the recovery process and opted to file legal action soon after discovering a settlement fund for DePuy ASR patients had formed.

Overview of DePuy Hip Replacement Symptoms

The DePuy ASR hip replacement settlement fund was established for patients who suffered complications from the metal on metal hip implant and were forced to undergo revision surgery since March 2015.

These DePuy ASR hip implants were subject to a massive market recall in August 2010, after numerous consumer reports indicated serious DePuy hip replacement symptoms. Many of these patients were forced to undergo revision surgery, which further compounded their medical condition.

The adverse DePuy hip replacement symptoms described in many of these claims are blamed on an allegedly defective design of the all-metal hip implant components, specifically the ball and socket joints. When these components interact, metal ions may be shed into the bloodstream and create a multitude of problems for patients including:

• Metallosis (blood metal poisoning)
• Debilitating Pain
• Fretting
• Corrosion
• Formation of Pseudotumors
• Tissue Death
• Infection
• Inflammation

Oftentimes revision surgery is necessary to resolve these problems, which is considered riskier than the initial implant surgery due to a higher risk of infection and other complications.

Even though these DePuy hip replacement symptoms can be devastating to patients, the manufacturing company allegedly failed to warn the general public. Lyle states they would not have opted for the DePuy ASR hip replacement system if the potential complications had been public knowledge.

Lyle’s DePuy metal hip lawsuit is being filed in MDL No. 2197, where it will stand alongside other claims alleging similar DePuy hip replacement symptoms. By joining and MDL, Lyle’s claim will avoid potential problems like conflicting rulings from different judges and will be streamlined through the litigation process.

This DePuy Metal Hip Lawsuit is Case No. 1:18-dp-20026-JJH, in the U.S. District Court of Northern Ohio, Western Division.